CLPT · ClearPoint Neuro, Inc. · Webcasts, Transcripts & Audio
$8.48
-0.01 (-0.12%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$271.82M
Shares
32.05M
Volume · Nov 13
505.62K
Avg daily vol (3M)
666.43K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
ClearPoint Neuro, Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for ClearPoint Neuro, Inc. (CLPT), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Earnings call
FY26 · Q3
2026-10-28
ClearPoint Neuro, Inc. (CLPT) Q3 2026 Earnings Call Transcript
Positive tone
AMT-130 regulatory pathway
Robotics and focused ultrasound investment
Eraflow product and clinical milestones
Revenue
$12.07M
▲ 36.3% YoY Diluted EPS
$-0.24
Gross margin
58.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q2
2026-08-03
ClearPoint Neuro, Inc. (CLPT) Q2 2026 Earnings Call Transcript
Confident tone
FDA regulatory pathway acceleration
Focused ultrasound partnership
Commercial readiness for partner drug launches
Revenue
$10.88M
▲ 18.1% YoY Diluted EPS
$-0.38
Gross margin
61.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-13
ClearPoint Neuro, Inc. (CLPT) Q1 2026 Earnings Call Transcript
Confident tone
Biopharma partner ecosystem and cell/gene therapy pipeline
Eeroflow acquisition integration
Expense growth and cash burn
Revenue
$12.13M
▲ 42.9% YoY Diluted EPS
$-0.32
Gross margin
64.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-17
ClearPoint Neuro, Inc. (CLPT) Q4 2025 Earnings Call Transcript
Confident tone
Four product categories / Fast Forward phase
Eris Holdings acquisition integration
Cell and gene therapy / Essential Everywhere strategy
Revenue
$10.41M*
▲ 34% YoY Gross margin
61.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-06
ClearPoint Neuro, Inc. (CLPT) Q3 2025 Earnings Call Transcript
Confident tone
IRRAS Merger
Biologics and Drug Delivery
CRO Facility / Preclinical Services
Revenue
$8.86M
▲ 9.1% YoY Diluted EPS
$-0.21
Gross margin
63.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-12
ClearPoint Neuro, Inc. (CLPT) Q2 2025 Earnings Call Transcript
Confident tone
Product introductions (ICT 3.0, PRISM Laser, OR expansion)
Cell and gene therapy ecosystem
Global installed base and regulatory clearances
Revenue
$9.21M
▲ 17.3% YoY Diluted EPS
$-0.21
Gross margin
60.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-13
ClearPoint Neuro, Inc. (CLPT) Q1 2025 Earnings Call Transcript
Confident tone
Capital equipment and site placements
Cell and gene therapy / biologics and drug delivery
Software and new product launches (3.0, PRISM)
Revenue
$8.48M
▲ 11.1% YoY Diluted EPS
$-0.22
Gross margin
60.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-26
ClearPoint Neuro, Inc. (CLPT) Q4 2024 Earnings Call Transcript
Confident tone
Cell and gene therapy delivery ecosystem
Fast. Forward strategic phase
New product launches and innovation
Revenue
$7.77M*
▲ 14.1% YoY Gross margin
61.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-07
ClearPoint Neuro, Inc. (CLPT) Q3 2024 Earnings Call Transcript
Confident tone
Biologics and Drug Delivery Growth
SmartFrame OR Expansion
Gross Margin Outlook
Revenue
$8.12M
▲ 41% YoY Diluted EPS
$-0.18
Gross margin
59.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-07
ClearPoint Neuro, Inc. (CLPT) Q2 2024 Earnings Call Transcript
Confident tone
Four-Pillar Growth Strategy
Capital Equipment and Software Expansion
New Product Launches and Innovation
Revenue
$7.86M
▲ 32.1% YoY Diluted EPS
$-0.16
Gross margin
63.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-07
ClearPoint Neuro, Inc. (CLPT) Q1 2024 Earnings Call Transcript
Confident tone
Capital placements (SmartFrame OR and PRISM Laser)
Four-pillar growth strategy
Biologics and drug delivery partners
Revenue
$7.64M
▲ 40.6% YoY Diluted EPS
$-0.16
Gross margin
59.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-01-08
ClearPoint Neuro, Inc. (CLPT) Q4 2023 Earnings Call Transcript
Confident tone
Biologics and Drug Delivery Growth
International Expansion and EU MDR Certification
Four-Pillar Growth Strategy
Revenue
$6.81M*
▲ 31.6% YoY Gross margin
58.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-09
ClearPoint Neuro, Inc. (CLPT) Q3 2023 Earnings Call Transcript
Revenue
$5.76M
▲ 12% YoY Diluted EPS
$-0.20
Gross margin
56.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-08
ClearPoint Neuro, Inc. (CLPT) Q2 2023 Earnings Call Transcript
Revenue
$5.95M
▲ 14.4% YoY Diluted EPS
$-0.29
Gross margin
52.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-11
ClearPoint Neuro, Inc. (CLPT) Q1 2023 Earnings Call Transcript
Revenue
$5.43M
▲ 8% YoY Diluted EPS
$-0.23
Gross margin
58.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-01-11
ClearPoint Neuro, Inc. (CLPT) Q4 2022 Earnings Call Transcript
Revenue
$5.17M*
▲ 20.8% YoY Gross margin
65.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-08
ClearPoint Neuro, Inc. (CLPT) Q3 2022 Earnings Call Transcript
Revenue
$5.15M
▲ 12.5% YoY Diluted EPS
$-0.15
Gross margin
71.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-09
ClearPoint Neuro, Inc. (CLPT) Q2 2022 Earnings Call Transcript
Revenue
$5.20M
▲ 52.4% YoY Diluted EPS
$-0.18
Gross margin
62.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-11
ClearPoint Neuro, Inc. (CLPT) Q1 2022 Earnings Call Transcript
Revenue
$5.03M
▲ 24.8% YoY Diluted EPS
$-0.17
Gross margin
64.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-14
ClearPoint Neuro, Inc. (CLPT) Q4 2021 Earnings Call Transcript
Revenue
$4.28M*
▲ 15.2% YoY Gross margin
74.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-09
ClearPoint Neuro, Inc. (CLPT) Q3 2021 Earnings Call Transcript
Revenue
$4.57M
▲ 30% YoY Diluted EPS
$-0.18
Gross margin
66.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-10
ClearPoint Neuro, Inc. (CLPT) Q2 2021 Earnings Call Transcript
Revenue
$3.41M
▲ 37.7% YoY Diluted EPS
$-0.17
Gross margin
66.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-11
ClearPoint Neuro, Inc. (CLPT) Q1 2021 Earnings Call Transcript
Revenue
$4.03M
▲ 29.3% YoY Diluted EPS
$-0.13
Gross margin
64.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-03-04
ClearPoint Neuro, Inc. (CLPT) Q4 2020 Earnings Call Transcript
Revenue
$3.72M*
▲ 15.7% YoY Gross margin
71.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-10
ClearPoint Neuro, Inc. (CLPT) Q3 2020 Earnings Call Transcript
Revenue
$3.52M
▲ 20.2% YoY Gross margin
74.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-12
ClearPoint Neuro, Inc. (CLPT) Q2 2020 Earnings Call Transcript
Revenue
$2.48M
▼ 4.9% YoY Gross margin
67.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-04-16
ClearPoint Neuro, Inc. (CLPT) Q1 2020 Earnings Call Transcript
Revenue
$3.12M
▲ 26% YoY Gross margin
70.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Showing 1–27 of 27 webcasts
Key facts
CIK
1285550
CUSIP
18507C103
13F (30d)
108 filings
83 filers
Visit website
Investor relations